All Articles

With gonorrhea becoming increasingly resistant to antibiotics, a new $2.6M grant fuels the development of a promising preventative vaccine platform.

Bhutan announces its first International Travel Mart, a bold move to attract elite partners and showcase the visionary Gelephu Mindfulness City.

Ryan’s Roundup offers a free platform for economic reconciliation, featuring Indigenous music, fashion, and business leaders to foster community connection.

Amity University's international workshop leverages AI and global expertise to forge a new path for digital accessibility in India's higher education.

The Chinese AI credit platform's latest ESG report signals a growing focus on sustainability and social impact amid tightening market and regulatory pressures.

A Shenzhen tech firm's portable monitor is a bestseller in Japan, shaking up mobile gaming with its dock-free Switch connectivity and versatile design.

The regional bank posted record earnings and boosted its dividend, defying market headwinds with exceptional efficiency and a surge in core customer deposits.

A new platform offers one subscription for ChatGPT, Claude, and Gemini with an encrypted, user-owned memory that challenges the AI industry's data-hungry model.

Backed by activist investor Irenic Capital, a new $220M blank-check firm hits Nasdaq, aiming to acquire a target in the aerospace or industrial sectors.

Brazil's new antimicrobial rules are shaking up the livestock industry. See how Phibro is pivoting from growth promotion to a digital, therapeutic future.

Biotech firm Tr1X unveils promising data for its novel cell therapies, offering a scalable new approach to treating autoimmune diseases like MS and GvHD.

Encoded Therapeutics is set to unveil pivotal data on ETX101, a one-time gene therapy showing promise in not just stopping seizures but reversing developmental delays.

Alibaba's top-ranked AI video model is now available via fal's API, shaking up the competitive generative media landscape with its advanced capabilities.

Dyno Therapeutics is using AI to design 'smart' viral vectors, promising safer, more effective treatments for untreatable genetic diseases.

Biotech firm Cellectis presents a new epigenetic platform that silences genes without cutting DNA, a potentially safer approach for cancer and liver disease.

Set to unveil its "best of both" PRINT™ platform, Addition Therapeutics aims to cure diseases from Fabry to HIV with a single, durable genetic medicine.

With its latest casino acquisition, the Snuneymuxw First Nation is becoming Canada's top Indigenous gaming operator, channeling profits into community prosperity.

American Overseas Group posts $10.8M net income, driven by underwriting discipline and strategic growth, while aggressively paying down its long-term debt.

After a major transformation, agilon health appoints a new CEO with deep payor and provider expertise to scale its value-based care model for seniors.

Umoja Biopharma's UB-VV500 aims to revolutionize myeloma care by creating a dual-antigen CAR T therapy directly inside the patient's body.